Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4,578,825
+$317,992 QoQ
Shares Held
18,029
+3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
#1,688
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CPC Advisors, LLC holds $7,718,083 across 7 Drug Manufacturers - General names. JNJ ranks #1 (59.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
18,029 | $4,578,825 | |
| 2 | LLY |
ELI LILLY & Co
|
1,261 | $1,512,481 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,842 | $493,697 | |
| 4 | ABBV |
AbbVie Inc.
|
1,704 | $428,794 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,937 | $244,720 | |
| 6 | NVS |
Novartis AG
|
1,516 | $237,587 | |
| 7 | AMGN |
Amgen Inc
|
613 | $221,979 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,578,825 | 18,029 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $4,260,833 | 17,431 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $878,709 | 4,246 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $791,928 | 4,271 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $980,960 | 6,422 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $890,063 | 5,367 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,401,367 | 9,690 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $987,917 | 6,096 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $893,037 | 6,110 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $4,666,921 | 29,502 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $4,556,745 | 29,072 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,693,526 | 30,135 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,021,711 | 30,339 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,889,105 | 25,091 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,376,664 | 19,115 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $664,385 | 4,067 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $759,920 | 4,281 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $721,326 | 4,070 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $710,966 | 4,156 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $684,114 | 4,236 | Shares | Sole | 2021-11-17 | |
| 2021-06-30 | $684,165 | 4,153 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $695,693 | 4,233 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $631,093 | 4,010 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $573,485 | 3,852 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $549,300 | 3,906 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $511,931 | 3,904 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||